Bristol-Myers Squibb Given Average Rating of “Buy” by Analysts (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) has been given a consensus rating of “Buy” by the seventeen analysts that are presently covering the stock, Analyst Ratings News reports. Eight equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $52.47.
BMY has been the subject of a number of recent research reports. Analysts at Jefferies Group raised their price target on shares of Bristol-Myers Squibb from $42.00 to $43.50 in a research note on Monday, July 14th. They now have a “hold” rating on the stock. Separately, analysts at Leerink Swann cut their price target on shares of Bristol-Myers Squibb from $62.00 to $55.00 in a research note on Tuesday, July 8th. Finally, analysts at Barclays downgraded shares of Bristol-Myers Squibb from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, July 2nd. They now have a $46.00 price target on the stock, down previously from $65.00.
Shares of Bristol-Myers Squibb (NYSE:BMY) opened at 48.92 on Friday. Bristol-Myers Squibb has a 52 week low of $41.11 and a 52 week high of $57.49. The stock has a 50-day moving average of $48.13 and a 200-day moving average of $50.93. The company has a market cap of $81.069 billion and a price-to-earnings ratio of 28.39.
Bristol-Myers Squibb (NYSE:BMY) last announced its earnings results on Tuesday, April 29th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.43 by $0.03. The company had revenue of $3.81 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was down .5% on a year-over-year basis. Analysts expect that Bristol-Myers Squibb will post $1.78 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, August 1st. Stockholders of record on Thursday, July 3rd will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.94%. The ex-dividend date is Tuesday, July 1st.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.